It is suspected that reduced UCP1 levels play important roles in the development of age-related type 2 diabetes, obesity, and various other diseases [38,39] and that the protective effect of UCP1 decreases with age. This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.